Piperazine
Spécifications
110-85-0Numéro CAS
203-808-3Numéro CE
piperazineNom IUPAC
C4H10N2Formule chimique
86.14 g/molMasse molaire
piperazine; 110-85-0; Diethylenediamine; 1,4-Diazacyclohexane; Hexahydropyrazine; Piperazin; Antiren; Piperazidine; Diethyleneimine; Dispermine; Lumbrical; Pipersol; Eraverm; 1,4-Piperazine; Wurmirazin; Uvilon; Piperazine, anhydrous; Worm-A-Ton; 1,4-Diethylenediamine; Pyrazine hexahydride; Hexahydro-1,4-diazine; Pyrazine, hexahydro-; Piperazine (USP); DTXSID1021164; NSC-474; 1RTM4PAL0V; Piperazine [USP]; FEMA NO. 4250; CHEBI:28568; P02CB01; DTXCID701164; 1,4 Diazacyclohexane; Vermizine; Ascalix; Ectodyne; Expelix; Wormex; Ins umuline rapide; 1,4 Piperazine; RefChem:6143; piperazine phosphate (1:1); 203-808-3; Vermex; Asca-Trol No. 3; Vermizine (TN); MFCD00005953; Piperazine-; NSC 474; Trimetazidine EP Impurity G; 1323940-30-2; NSC474; Piperazine anhydrous; Eraverm (VAN); Piperazin [German]; NCGC00094762-03; Upixon; Piperazin [Germany]; 31977-51-2; CAS-110-85-0; PZE; CCRIS 5950; HSDB 1093; EINECS 203-808-3; UNII-1RTM4PAL0V; UN2579; BRN 0102555; piperizine; piperzine; piprazine; 7-piperazine; Piperazine,anhydrous; Piperazine, 99%; Tasnon (Salt/Mix); PIPERAZINUM; Exelmin (Salt/Mix); Vermidol (Salt/Mix); Piperazine - anhydrous; Vermizine (Salt/Mix); Spectrum_001113; PIPERAZINE [II]; PIPERAZINE [MI]; Spectrum5_001817; PIPERAZINE [FHFI]; PIPERAZINE [HSDB]; SCHEMBL238; WLN: T6M DMTJ; PIPERAZINE [VANDF]; PIPERAZINUM [HPUS]; Epitope ID:768767; EC 203-808-3; PIPERAZINE [MART.]; SCHEMBL1640; SCHEMBL8372; Piperazine, p.a., 98%; CHEMBL1412; NCIOpen2_000984; NCIOpen2_000988; NCIOpen2_001024; NCIOpen2_001031; NCIOpen2_001033; NCIOpen2_001071; NCIOpen2_001073; NCIOpen2_001111; NCIOpen2_001151; NCIOpen2_001231; NCIOpen2_001262; NCIOpen2_001269; NCIOpen2_004830; NCIOpen2_004834; NCIOpen2_004862; NCIOpen2_004874; NCIOpen2_004904; NCIOpen2_004910; NCIOpen2_004914; NCIOpen2_004942; NCIOpen2_004952; NCIOpen2_004954; NCIOpen2_004982; NCIOpen2_004992; NCIOpen2_004994; NCIOpen2_005022; NCIOpen2_005032; NCIOpen2_005034; NCIOpen2_005062; NCIOpen2_005072; NCIOpen2_005102; NCIOpen2_005108; NCIOpen2_005145; NCIOpen2_005182; NCIOpen2_005185; NCIOpen2_005187; NCIOpen2_005200; NCIOpen2_005575; NCIOpen2_005980; NCIOpen2_009422; PIPERAZINE [USP-RS]; PIPERAZINE [WHO-DD]; SCHEMBL77543; KBioSS_001593; 5-23-01-00030 (Beilstein Handbook Reference); BIDD:GT0273; DivK1c_000038; SCHEMBL215254; SCHEMBL524620; SCHEMBL524861; SCHEMBL908308; SPECTRUM1500490; Piperazine, analytical standard; orb1182253; orb2893579; SCHEMBL1663725; SCHEMBL6239923; SCHEMBL6575336; SCHEMBL8010246; PIPERAZINE [GREEN BOOK]; HMS500B20; KBio1_000038; KBio2_001593; KBio2_004161; KBio2_006729; MSK7186; NINDS_000038; HMS1920H20; HMS2092A03; HMS3885L08; Pharmakon1600-01500490; PIPERAZINE [USP MONOGRAPH]; HY-B0912; Piperazine, ReagentPlus(R), 99%; STR00051; Tox21_113564; Tox21_202242; Tox21_300104; EBC-03034; MSK7186-100M; NSC757283; STL169348; Piperazine [UN2579] [Corrosive]; AKOS000269028; MSK7186-1000M; CCG-212753; CS-4381; DB00592; FP31694; LF-0561; NSC-757283; UN 2579; IDI1_000038; NCGC00094762-01; NCGC00094762-02; NCGC00094762-04; NCGC00094762-05; NCGC00094762-07; NCGC00094762-08; NCGC00254077-01; NCGC00259791-01; Piperazine, anhydrous, >=99.0% (T); BP-31252; SBI-0051485.P003; Piperazine Solution in Methanol, 100ug/mL; NS00008207; P0446; P0447; Piperazine Solution in Methanol, 1000ug/mL; EN300-33920; C07973; D00807; T73197; AB00052073_03; 1,4-Diazacyclohexane; 1,4-Piperazine; Antiren;; AG-690/11351756; F097595; Piperazine, BioUltra, anhydrous, >=99.0% (T); Q409292; SR-05000001700; SR-05000001700-1; BRD-K13249881-001-02-3; F0001-0226; Z1245537944; InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H; Piperazine, United States Pharmacopeia (USP) Reference Standard; TRIMETAZIDINE DIHYDROCHLORIDE IMPURITY G [EP IMPURITY]Synonymes
